Glaucoma has been recognized as one of the commonest causes of blindness worldwide. Approximately 2.1% of adults over the age of 40 have glaucoma [1]. There are different treatments available to treat raised intraocular pressures (IOP). Selective laser trabeculoplasty (SLT) has the advantage of being able to perform in clinic settings. It also has the advantage of decreasing tissue damage and scarring compared to Argon laser trabeculoplasty (ALT) [2].Selective laser trabeculoplasty has been offered as the first line of treatment for glaucoma in the past few years by various institutions [3]. The suc-cess rate on reducing IOP by SLT ranged from 6.9-35.9% [4,5]. This study analyses IOP reduction at a 6-week follow-up when SLT was carried out in glaucoma patients.
MaterIal and Methods study designWe performed a retrospective analysis on glaucoma patients who underwent SLT. Patients included were those with primary open-angle glaucoma (POAG) and ocular hypertension (OHT), pigmentary glaucoma or pseudoexfoliation, age ≥ 18 years This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.